JPRN-jRCT2080220185未知3 期
HERA study: A study of Intravenous R597 (Trastuzumab) in Women with HER2-Positive Primary Breast Cancer
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •Female patients, >=18 years of age, with HER2-positive primary breast cancer;
- •Completion of adjuvant systemic chemotherapy and radiotherapy, if applicable.
- •Exclusion criteria:
- •History of prior invasive breast cancer;
- •Prior use of any anti-HER2 therapy.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Control of bleeding in prostate surgeryBPH.Dysplasia of prostate Low grade dysplasiaIRCT138904164345N1Guilan University of Medical Sciences80
尚未招募
2 期
A study on comparison of the effect of intravenous Tranexamic acid and sublingual Misoprostol in reducing blood loss during caeserean sectioCTRI/2024/05/067355SRI MANAKULA VINAYAGAR MEDICAL COLLEGE AND HOSPITA
未知
3 期
Correction study of intravenous injections of R744 to Hemodialysis patients ( Phase III study ).Renal anemiaJPRN-jRCT2080220345Chugai Pharmaceutical Co., Ltd.
已完成
2 期
A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME)Macular EdemaDiabetic RetinopathyNCT03071068ThromboGenics49
招募中
1 期
A Phase-I clinical study of intravenous AntiPlatelet, AntiCoagulant (APAC) in healthy subjects.CTRI/2023/04/051500Cadila Pharmaceutical Limited